ADVB · XBRL financial data
Advanced Biomed financial statements, every quarter
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (ADVB's year ends in late June)
| In thousands of dollars | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | †Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | year only |
| Research and development | 243 | 250 | 234* | 236 | 186 | 243 | — |
| General and administrative | 282 | 512 | 978* | 288 | 210 | 277 | 3,981* |
| Total operating expenses | 526 | 763 | 1,213* | 524 | 397 | 520 | 5,050* |
| Operating income (loss) | — | — | year only | — | — | — | year only |
| Interest income | 15 | (0)* | 10* | 0 | 9 | — | — |
| Other income (expense) | (398) | (621) | 501* | 137 | 43 | 31 | (232)* |
| Income tax expense (benefit) | — | — | — | — | — | — | year only |
| Net income (loss) | (908) | (1,384) | (702)* | (387) | 6,858 | (489) | 695* |
| Earnings per share, basic USD per share | (0.04) | (0.07) | (0.03)* | (0.02) | 0.31 | (0.38) | — |
| Earnings per share, diluted USD per share | (0.04) | (0.07) | (0.03)* | (0.02) | 0.31 | (0.38) | — |
| Weighted average shares, basic thousands of shares | 20,000 | 20,479 | 21,635* | 21,640 | 21,640 | 1,285 | — |
| Weighted average shares, diluted thousands of shares | 20,000 | 20,479 | 21,635* | 21,640 | 21,640 | 1,285 | — |
- † Share count changed about 1/16 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal quarters (ADVB's year ends in late June)
| In thousands of dollars | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | †Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2,657 | 5,184 | 2,904 | 2,657 | 2,605 | 2,603 | 386 |
| Prepaid and other current assets | 482 | 2,547 | 3,129 | 3,188 | 8,127 | 7,924 | 13,364 |
| Total current assets | 3,139 | 7,731 | 6,033 | 5,844 | 10,732 | 10,526 | 13,750 |
| Property and equipment, net | 401 | 355 | 331 | 281 | 97 | 87 | — |
| Right-of-use asset | 241 | 181 | 65 | 43 | 21 | 31 | — |
| Total assets | 4,504 | 8,288 | 6,512 | 6,243 | 10,851 | 10,646 | 13,751 |
| Accounts payable | 618 | 619 | 633 | 642 | 369 | 377 | — |
| Accrued liabilities | — | — | 448 | — | 224 | 239 | 232 |
| Total current liabilities | 3,829 | 4,113 | 2,889 | 3,045 | 1,254 | 1,426 | 1,474 |
| Lease liability, non-current | 56 | 44 | 6 | 3 | 1 | 11 | — |
| Total liabilities | 3,885 | 4,158 | 3,035 | 3,239 | 1,369 | 1,437 | 1,474 |
| Accumulated deficit | (17,148) | (18,531) | (19,233) | (19,620) | (12,762) | (13,251) | (12,556) |
| Total stockholders' equity | 619 | 4,130 | 3,478 | 3,004 | 9,482 | 9,210 | 12,277 |
| Total liabilities and equity | 4,504 | 8,288 | 6,512 | 6,243 | 10,851 | 10,646 | 13,751 |
| Common shares outstanding (cover page) thousands of shares | 21,640 | 21,640 | 21,640 | 21,640 | 21,640 | 1,382 | 1,652 |
- † Share count changed about 1/16 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal quarters (ADVB's year ends in late June)
| In thousands of dollars | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | †Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|
| Net income (loss) | (908) | (1,384) | (702)* | (387) | 6,858 | (489) | 695* |
| Stock-based compensation | — | — | — | — | — | — | year only |
| Net cash from operating activities | (842)* | (3,410)* | (1,544)* | (610) | (514)* | (240)* | (583)* |
| Purchases of property and equipment | (11)* | 2* | 20* | 2 | 13* | 1* | — |
| Net cash from investing activities | 11* | (2)* | (20)* | (2) | (13)* | (1)* | (2,490)* |
| Proceeds from issuing common stock | — | — | (109)* | — | — | — | 0* |
| Net cash from financing activities | 408* | 5,899* | (765)* | 447 | 315* | 268* | 937* |
| Net change in cash | 10* | 2,527* | (2,280)* | (247) | (46)* | (2)* | (2,223)* |
- † Share count changed about 1/16 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Advanced Biomed | 386 | year only | (583)* | 1.7M | 0.7 quarters | 10-KJun 30, 2026 |
| Aclarion | 16,285 | 25 | (2,657)* | 2.9M | 6.1 quarters | 10-QJun 30, 2026 |
| BioNexus Gene Lab | 1,233 | 76 | (422)* | 2.9M | 2.9 quarters | 10-QJun 30, 2026 |
| Ludwig Enterprises | 18 | not reported | (153) | 167.2M | 1.3 quarters | 10-QMar 31, 2026 |
| CapForce | 144 | 50,000 | (618)* | 12.4M | 0.2 quarters | 10-QJun 30, 2026 |
| American Shared Hospital Services | 6,511 | 8,430 | 2,236* | 6.7M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.